	Emerging therapeutic targets beyond amyloid and tau in Alzheimer's Disease: Implications for lifestyle, metabolism and preventive medicine. Wiad Lek Izhytska N, Sobczyk KA, Ogrodnik KW, Mazurkiewicz M, Malentowicz D, Szafraniec NJ, Bro, Sa, Pastuszka M. PMID: 42748320 [PubMed - indexed for MEDLINE]
	Alzheimer's Co-Pathology Burden on Basal Forebrain Atrophy and Cognitive Impairment in Dementia with Lewy Bodies: A Cross-Sectional Pilot Study. Ann Neurol Urso D, Giannelli T, Tafuri B, Giannoni-Luza S, Gnoni V, Giugno A, Vilella D, Zecca C, De Blasi R, Nigro S, Aarsland D, Logroscino G. PMID: 42747246 [PubMed - as supplied by publisher]
	Advances in N- and S-Heterocycles as c-Jun-N-Terminal Kinase 3 Inhibitors for Alzheimer's Disease Treatment. Drug Dev Res Yadav P, Mishra D, Singh R. PMID: 42747078 [PubMed - indexed for MEDLINE]
	Validation of plasma core biomarkers of Alzheimer's disease: A multicenter study in usual practice conditions. J Alzheimers Dis Sánchez-Soblechero A, Villarejo A, Carreras MT, Berbel Á, Puertas C, Fernández-Bullido Y, Vieira A, Gundín I, Blanco-Palmero V, González-Sánchez M, Llamas S, Lapeña T, de Luis P, Lucio B, Ibáñez MD, Heredia P, Grandas F, Olazarán J. PMID: 42746979 [PubMed - as supplied by publisher]
	Recognition memory as a neuropsychological marker of progression in early-stage Alzheimer's disease: a 24-month prospective cohort study. J Clin Exp Neuropsychol Russo MJ, Bueri J, Alba-Ferrara L, Sevlever G, Allegri RF. PMID: 42746710 [PubMed - as supplied by publisher]
	Designing intranasal formulations for Alzheimer's disease: A material-based perspective. Tzu Chi Med J Chen YS, Huang HY. PMID: 42746628 [PubMed]
	Clinical Practice Outcomes With Lecanemab for Alzheimer Disease. Neurol Open Access Liu AJ, Moghadam AA, Alam MS, Lutz MW, Navarra A, Luo S, Wang LA, Petrella JR, Whitson H, O'Brien RJ, Johnson KG, Parker D, Beam C, Sanfilippo M, Al-Sahlani H, Cobb S, Liu MY, Doraiswamy PM. PMID: 42746606 [PubMed]
	Investigating oral blarcamesine for treatment of early Alzheimer's disease. Expert Opin Pharmacother Chandrasekaran A, Paget-Blanc A, Decourt B, Sabbagh MN. PMID: 42745524 [PubMed - as supplied by publisher]
	Enhancing Alzheimer's disease diagnosis in primary care through targeted screening of people at risk of developing dementia - study design and feasibility assessment of the PREDEM primary care study. Alzheimers Res Ther Aye S, Åhrberg S, Carlsson AC, Hasselström J, Alshamani I, Wallen S, van den Hurk W, Lund L, Jejcic A, Broome ST, Duran Sidera A, Tjernberg L, Jönsson L, Schedin-Weiss S. PMID: 42745326 [PubMed - indexed for MEDLINE]
	Alternative splicing in Alzheimer's disease: event-level evidence, risk-locus biology, and RNA-based therapeutic perspectives. Gene Li J, Yue D, Xie W, Xiong Z, Wang X. PMID: 42744164 [PubMed - as supplied by publisher]
	Autopsy findings in Alzheimer's disease clinical trial participants demonstrate a high frequency of off-target coexisting pathologic features. J Prev Alzheimers Dis Coskun EP, Barber J, Bojarski L, McLouth CJ, Abner EL, Van Eldik LJ, Nelson PT, Jicha GA. PMID: 42743907 [PubMed - as supplied by publisher]
	Pharmacological modulation of cGAS-STING-NLRP3 signaling by nano-immunomodulators in Alzheimer and Parkinson disease. Inflammopharmacology Abdel-Rasol MA. PMID: 42742907 [PubMed - as supplied by publisher]
	A new era of genome-wide association studies in the field of Alzheimer's disease and overlapping co-pathologies: lessons learned from a neuropathology-centered approach. Acta Neuropathol Laureyssen C, Thal DR, Sleegers K. PMID: 42742642 [PubMed - indexed for MEDLINE]
	Correlation between MMP-3-1171 5A/6A polymorphism and the risk of Alzheimer's disease: A meta-analysis. Medicine (Baltimore) Wang Y, Zhu S, Ma Y, Chen X, Zhou M. PMID: 42742624 [PubMed - indexed for MEDLINE]
	Social Media Claims About Blood Tests for Alzheimer's Disease and Dementia: A Cross-Sectional Content Analysis. J Am Geriatr Soc Sujana RS, McCaffery KJ, Nickel B, Fox R, Naganathan V, Cumming RG, Smith J. PMID: 42742271 [PubMed - as supplied by publisher]
	Digital cognitive phenotyping enhances risk stratification in preclinical Alzheimer's disease. Alzheimers Dement Vanderlip CR, Stark CEL. PMID: 42741980 [PubMed - indexed for MEDLINE]
	Alzheimer's disease heterogeneity and co-pathologies: Defining novel targets, biomarkers, modalities, and research methodologies. Alzheimers Dement (N Y) Tansey MG, Bozeat S, Ackerman P, Atri A, Barnum CJ, Brundin P, de Carvalho CA, Fleisher AS, Graf A, Head E, Kerchner GA, Kolb HC, Koyama A, Kozberg M, Leyns CEG, Llibre-Guerra JJ, Mattsson-Carlgren N, McKissock D, Murray ME, Rosenthal LS, Rubel C, Schindler SE, Schneider JA, Schwarz AJ, Scott KM, Seredenina T, Tosun D, Wallings RL, Wang H, Wilcock DM, Carrillo M, Mahinrad S, Weber CJ. PMID: 42741654 [PubMed]
	Utilising speech-derived biomarkers to detect Alzheimer's disease with BERT-based language models: a machine learning study. Front Artif Intell Khanna Z, Ho D, Remus A, Raczkowska M, Montalan R, Saha P. PMID: 42741373 [PubMed]
	Interpretable machine learning model based on multimodal MRI radiomics for Alzheimer's disease diagnosis. Front Aging Neurosci Keranmu N, Aizezi D, Pan X, Yang L, Liu Y, Liu J. PMID: 42741328 [PubMed]
	AST/ALT, APOE Îµ4, and Alzheimer's disease progression: A longitudinal cohort study. Alzheimers Dement (Amst) Ahn YH, Yang CM, Kim DJ, Lee SH, Jung YH, Lee SY, Yoon SH, Alzheimer's Disease Neuroimaging Initiative. PMID: 42741023 [PubMed]

Articles 1 - 20 / 72271

Page 1 of 3614



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy